GL1X · GenesisL1 explorer

MolNFT v1 · #175006 · protein

Crystal structure of SETDB1 tudor domain in complexed with compound 6

7CD9 · Histone-lysine N-methyltransferase SETDB1: “Crystal structure of SETDB1 tudor domain in complexed with compound 6”. X-ray diffraction, 1 ligand (FVR), 6 pockets (best druggability 0.84). MolNFT v1 #175006 on GenesisL1: 3D structure…

PDB
7CD9
Type
protein
Length
430 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SETDB1
EC
2.1.1.-
UniProt
Q15047
Ligands
FVR
Pockets
6 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHistone-lysine N-methyltransferase SETDB1 (EC 2.1.1.-)protein21515% helix, 46% strandQ15047

Ligands and binding sites

  • FVR · 3-methyl-2-[[(3R,5R)-1-methyl-5-(4-phenylmethoxyphenyl)piperidin-3-yl]amino]-5H-pyrrolo[3,2-d]pyrimidin-4-one · ligand · 2 copies · chains A, B
  • CIT · Citric acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19980.840.8596FVR, CIT
21450.500.7921empty
31550.480.7719empty
4770.450.8115empty
5590.440.8312empty

Interfaces

1 interface between chains.

  • A–B · 886 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 7CD9 · Crystal Structure of SETDB1 tudor domain in complexed with Compound 6 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q15047 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase SETDB1 (Q15047) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.